AIDS/HIV is a chronic pandemic disease with significant morbidity and mortality. Although with the advent of HAART an increase in life expectancy and improved QoL has been noticed, evidences regarding prevalence of mental disorders among PLHIV are largely ambiguous. The present study aims to systematically review the evidences about the mental complications in PLHIV before and after HAART therapy. Literature search was conducted for past ten years (. from 2008 to 2019) using the electronic data bases like PubMed, Googlescholar, Google using combination of keywords “AIDS” OR “HIV” AND “quality of life” OR “health related quality of life” AND “neurocognition”, OR “cognitive deficit” OR “psychological complications” OR “mental health” OR “cognitive impairment” OR “depression” OR “anxiety” OR “dementia” AND “randomized controlled trials” OR “randomized clinical trials”, OR “cohort study”, OR “meta-analysis”, OR “systemic review” OR “study”. A total of 27 studies were included in the current systematic review in which 25 were cross sectional studies and 2 were reviews. These 27 studies recorded the neuropsychological variables either as a component of HRQoL/QoL or through usage of specific tools for assessment of depression, anxiety and HAND. Overall based upon the included studies it is evident that the enhanced coexistence of depression, anxiety and HAND with AIDS/HIV is common worldwide. Further, it was observed that the role of HAART in reducing the prevalence of neuropsychological disorders with disease progression is largely meager. It is recommended that baseline assessment of HRQoL, immune markers, and neuropsychological disorders may serve as better treatment strategy with improved outcomes. Further, considering the serious repercussions of mental disorders on HRQoL, it would be beneficial to incorporate additional treatment regimen for them in addition to HAART from the beginning. | Quality of life with mental health HIV-infected patients in India before and after antiretroviral therapy (ART)
